NCNA
Price
$0.05
Change
-$0.01 (-16.67%)
Updated
Jul 3 closing price
Capitalization
20.45M
NRXP
Price
$3.38
Change
+$0.06 (+1.81%)
Updated
Jul 3 closing price
Capitalization
65.92M
Interact to see
Advertisement

NCNA vs NRXP

Header iconNCNA vs NRXP Comparison
Open Charts NCNA vs NRXPBanner chart's image
NuCana
Price$0.05
Change-$0.01 (-16.67%)
Volume$43.43M
Capitalization20.45M
NRX Pharmaceuticals
Price$3.38
Change+$0.06 (+1.81%)
Volume$93.87K
Capitalization65.92M
NCNA vs NRXP Comparison Chart in %
Loading...
NCNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NCNA vs. NRXP commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NCNA is a StrongBuy and NRXP is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (NCNA: $0.05 vs. NRXP: $3.38)
Brand notoriety: NCNA and NRXP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NCNA: 34% vs. NRXP: 30%
Market capitalization -- NCNA: $20.45M vs. NRXP: $65.92M
NCNA [@Biotechnology] is valued at $20.45M. NRXP’s [@Biotechnology] market capitalization is $65.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NCNA’s FA Score shows that 0 FA rating(s) are green whileNRXP’s FA Score has 0 green FA rating(s).

  • NCNA’s FA Score: 0 green, 5 red.
  • NRXP’s FA Score: 0 green, 5 red.
According to our system of comparison, NRXP is a better buy in the long-term than NCNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NCNA’s TA Score shows that 3 TA indicator(s) are bullish while NRXP’s TA Score has 3 bullish TA indicator(s).

  • NCNA’s TA Score: 3 bullish, 3 bearish.
  • NRXP’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, NCNA is a better buy in the short-term than NRXP.

Price Growth

NCNA (@Biotechnology) experienced а -35.11% price change this week, while NRXP (@Biotechnology) price change was -3.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

NCNA is expected to report earnings on Jun 02, 2025.

NRXP is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRXP($65.9M) has a higher market cap than NCNA($20.5M). NRXP YTD gains are higher at: 53.636 vs. NCNA (-95.496). NCNA has higher annual earnings (EBITDA): -16.98M vs. NRXP (-24.11M). NRXP has more cash in the bank: 5.55M vs. NCNA (3.95M). NCNA has less debt than NRXP: NCNA (173K) vs NRXP (8.4M). NCNA (0) and NRXP (0) have equivalent revenues.
NCNANRXPNCNA / NRXP
Capitalization20.5M65.9M31%
EBITDA-16.98M-24.11M70%
Gain YTD-95.49653.636-178%
P/E RatioN/A0.36-
Revenue00-
Total Cash3.95M5.55M71%
Total Debt173K8.4M2%
FUNDAMENTALS RATINGS
NCNA vs NRXP: Fundamental Ratings
NCNA
NRXP
OUTLOOK RATING
1..100
8972
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
9737
P/E GROWTH RATING
1..100
10094
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NCNA's Valuation (39) in the Biotechnology industry is in the same range as NRXP (57) in the null industry. This means that NCNA’s stock grew similarly to NRXP’s over the last 12 months.

NCNA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as NRXP (100) in the null industry. This means that NCNA’s stock grew similarly to NRXP’s over the last 12 months.

NCNA's SMR Rating (99) in the Biotechnology industry is in the same range as NRXP (100) in the null industry. This means that NCNA’s stock grew similarly to NRXP’s over the last 12 months.

NRXP's Price Growth Rating (37) in the null industry is somewhat better than the same rating for NCNA (97) in the Biotechnology industry. This means that NRXP’s stock grew somewhat faster than NCNA’s over the last 12 months.

NRXP's P/E Growth Rating (94) in the null industry is in the same range as NCNA (100) in the Biotechnology industry. This means that NRXP’s stock grew similarly to NCNA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NCNANRXP
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
71%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 24 days ago
79%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
NCNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KSIOF4.380.01
+0.14%
kneat.com, Inc.
ACCYY10.91N/A
N/A
Accor SA Ltd.
AUHEF1.27N/A
N/A
Anhui Expressway Co Ltd.
DGDCF0.10N/A
N/A
Dynasty Gold Corp.
MIFF27.00N/A
N/A
Mifflinburg Bancorp, Inc.

NRXP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRXP has been closely correlated with RNAC. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRXP jumps, then RNAC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXP
1D Price
Change %
NRXP100%
+1.81%
RNAC - NRXP
86%
Closely correlated
-1.41%
NCNA - NRXP
85%
Closely correlated
-5.13%
TAOX - NRXP
84%
Closely correlated
+5.20%
AGEN - NRXP
83%
Closely correlated
+10.16%
ALLR - NRXP
81%
Closely correlated
+1.00%
More